Coronavirus vaccine trial starts today
Published: 02:47 PM, 16 March 2020 Updated: 05:14 PM, 16 March 2020
The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday in the US, according to a government official.
The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.
Public health officials say it will take a year to 18 months to fully validate any potential vaccine.
Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.
Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines - shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.
Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.
Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases.
That still would be a record-setting pace. But manufacturers know the wait - required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm - is hard for a frightened public.
President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.”
Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the US, the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.
For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia.
The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover. - AP
- Coronavirus cases surpass 6 million
- 10 killed as minibus hits roadside bomb in Somalia
- Elderly woman dies of COVID-19 in Chattogram
- Girls ahead in GPA-5, boys in pass rate
- La Liga clubs to resume full training from Monday
- 8 launches fined for taking extra passengers
- Poverty couldn`t stop Asmani
- Two more labs to detect coronavirus in Capital
- Girl commits suicide after failing in SSC exam
- 19 militants killed in military drive in Egypt
- Another 167 UK nationals leave Sylhet
- Lalmonirhat reports nine new coronavirus cases
- BNP does not think of toiling masses: Hasan Mahmud
- Amirul who took part SSC exam after burying father got GPA-5
- BFDC ready for shooting
- Malaysia’s labour market may open in Jul, BD ready
- Gunmen kill 20 in Burkina Faso
- Peru reports more than 7,000 COVID-19 cases in a day
- ‘Alor Guerrilla’ running day and night
- Coronavirus cases exceed 400,000 in Russia
- Shujeo Shyam contracts COVID-19
- Govt provides relief assistance to more than 6 crore people
- Train runs maintaining health rules: Sujan
- Noakhali reports 90 coronavirus cases in a day
- BNP leaders passing leisure time
- 5 more test positive for COVID-19 in Trishal
- 25 US cities impose curfews as protests continue
- Locust attack in India ‘a result of sin’: Zaira Wasim
- Woman dies with fever and breathing difficulties in Rajshahi
- World No Tobacco Day 2020 being observed aims to protect youth from tobacco
- All News »
- Noble got married for 3rd time seven months ago!
- Noble made his wife Salsabil a model in music video
- 1532 new infected in 24 hrs, 28 die
- Thousands offer Eid prayers in knee-deep water
- Three killed as microbus falls into Munshiganj ditch
- 23 die, highest infection recorded in last 24 hrs
- Noble faces RAB interrogation
- Highest 1,975 COVID-19 cases in a day, 21 die
- 22 die, 1541 infected in last 24 hours
- 4 cops charged for killing a black man in US
- Over 2000 infected in 24 hours, 15 dead
- Karate coach Humayun Kabir Jewel dies
- Fire at United Hospital: 5 COVID-19 patients die
- Offices resume from May 31
- Wuhan lab had three live bat coronaviruses
- SSC-equivalent results published, pass 82.87 pc
- 1166 new infected in 24 hrs, 21 die
- Country sees highest deaths in a day
- Record deaths, infections in 24 hours
- Electronic mask developed to prevent coronavirus!
- Coronavirus death toll rises to 342,396 globally
- 26 Bangladeshis shot dead in Libya
- Happy birthday ‘Legendary Actor’ Humayun Faridi
- India backs hydroxychloroquine for coronavirus treatment
- A thrilling operation by Police: 6 youths rescued from Sundarbans
- SSC result today: How to pre-register
- Former national footballer Salauddin passes away
- Eid-ul-Fitr to be celebrated tomorrow
- Brazil’s COVID-19 deaths surge past Spain
- Xi Jinping asks Chinese military to prepare for battle